Skip to main navigation Skip to search Skip to main content

Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy

  • Jean Pascal Henry Machiels*
  • , Aline Vanmaanen
  • , Jean Marie Vandenbulcke
  • , Bertrand Filleul
  • , Emmanuel Seront
  • , Stéphanie Henry
  • , Lionel D’Hondt
  • , Christophe Lonchay
  • , Stéphane Holbrechts
  • , Petra Boegner
  • , Dany Brohee
  • , Didierde Quanter
  • , Ingrid Louviaux
  • , Brieuc Sautois
  • , Nicolas Whenham
  • , Guy Berchem
  • , Brigitte Vanderschueren
  • , Christel Fontaine
  • , Sandra Schmitz
  • , Aline Gillain
  • Joelle Schoonjans, Sylvie Rottey
*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science